C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/5025 (2006.01) A61K 31/517 (2006.01) C07D 241/00 (2006.01) C07D 249/00 (2006.01)
Patent
CA 2471087
The invention relates to derivatives of the pyrazolyl[1,2,4]triazolo[4,3- .alpha.]quinoxaline according to formula (1), or of its analog in the form of the pyrazolyl-substituted tetrazolo[1,5-.alpha.]quinoxalines according to formula (2). The substances according to formula 1 or 2, in this form or in the form of their pharmaceutically acceptable salts, are suitable as active agents, especially as adenosine receptor ligands.
L'invention concerne des dérivés de pyrazolyl[1,2,4]triazolo[4,3-.alpha.]quinoxaline de formule 1 (1), ou de l'analogon sous forme de tétrazolo[1,5-.alpha.]quinoxaline substituée par pyrazolyl de formule 2 (2). Les substances selon les formules 1 ou 2, sous cette forme ou sous forme de sels pharmaceutiquement acceptables, servent d'agents actifs, notamment de ligands de récepteurs de l'adénosine.
Matuszczak Barbara
Mueller Christa E.
Borden Ladner Gervais Llp
Jsw-Research Forschungslabor Gmbh
LandOfFree
Pyrazolyl-substituted triazoloquinoxalines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolyl-substituted triazoloquinoxalines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolyl-substituted triazoloquinoxalines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1482358